Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) EPS (Basic) (2016 - 2025)

Lifecore Biomedical, Inc. \De\ (LFCR) has 16 years of EPS (Basic) data on record, last reported at -$0.03 in Q2 2025.

  • For Q2 2025, EPS (Basic) rose 87.5% year-over-year to -$0.03; the TTM value through May 2025 reached -$1.27, down 376.09%, while the annual FY2025 figure was -$1.27, 425.64% down from the prior year.
  • EPS (Basic) reached -$0.03 in Q2 2025 per LFCR's latest filing, up from -$0.46 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $0.58 in Q1 2024 and bottomed at -$1.23 in Q2 2023.
  • Average EPS (Basic) over 5 years is -$0.21, with a median of -$0.25 recorded in 2021.
  • Peak YoY movement for EPS (Basic): crashed 925.0% in 2023, then surged 256.76% in 2024.
  • A 5-year view of EPS (Basic) shows it stood at $0.12 in 2021, then tumbled by 358.33% to -$0.31 in 2022, then soared by 251.61% to $0.47 in 2023, then crashed by 153.19% to -$0.25 in 2024, then soared by 88.0% to -$0.03 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Basic) were -$0.03 in Q2 2025, -$0.46 in Q1 2025, and -$0.25 in Q4 2024.